AI-enabled precision medicine company × OneMedNet Corporation
OneMedNet announced a multi-year data licensing agreement with an unnamed AI precision medicine company. The deal, described as a "seven-figure contract," provides the buyer with access to de-identified clinical and imaging data to train AI models and create a derivative dataset for its own clients. The agreement includes a revenue-sharing structure where OneMedNet receives additional payments from the sublicensing of the derivative data product.
The asset
A multi-year license for de-identified, multimodal, longitudinal clinical data delivered via OneMedNet's iRWD™ platform.
The record
- Seller status
- Going concern
- Sector
- Real-world data provider
- Modalities
- clinical_data, imaging_data
- Jurisdiction
- US
- Personal data
- Data is described as de-identified at the source.
What it means if you hold data
This deal exemplifies the shift towards long-term, value-based data partnerships in the AI healthcare sector. Instead of one-time data pulls, AI developers are seeking continuous access to high-quality, regulatory-grade data and are structuring deals that include revenue sharing on derivative products.